244 related articles for article (PubMed ID: 8418998)
1. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
Kidwell GA; Greenspon AJ; Greenberg RM; Volosin KJ
Circulation; 1993 Jan; 87(1):118-25. PubMed ID: 8418998
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
Aizawa Y; Chinushi M; Naitoh N; Shibata A
Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
[TBL] [Abstract][Full Text] [Related]
4. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia.
Gorgels AP; van den Dool A; Hofs A; Mulleneers R; Smeets JL; Vos MA; Wellens HJ
Am J Cardiol; 1996 Jul; 78(1):43-6. PubMed ID: 8712116
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
Kus T; Costi P; Dubuc M; Shenasa M
Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
[TBL] [Abstract][Full Text] [Related]
6. Procainamide-induced changes in reentrant ventricular tachycardia with special reference to the tachycardia-interrupting critical paced cycle length during transient entrainment with rapid pacing.
Aizawa Y; Naitoh N; Washizuka T; Kitazawa H; Takahashi K; Kodama I; Shibata A
Jpn Heart J; 1994 Sep; 35(5):611-23. PubMed ID: 7830326
[TBL] [Abstract][Full Text] [Related]
7. Prediction of antiarrhythmic efficacy of class I and III agents in patients with ventricular tachycardia by signal-averaged ECG analysis.
Kulakowski P; Bashir Y; Heald S; Paul V; Anderson MH; Gibson S; Malik M; Camm AJ
Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2116-21. PubMed ID: 1279610
[TBL] [Abstract][Full Text] [Related]
8. Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing.
Naitoh N; Washizuka T; Takahashi K; Aizawa Y
Jpn Circ J; 1998 Apr; 62(4):267-73. PubMed ID: 9583460
[TBL] [Abstract][Full Text] [Related]
9. Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia.
Grimm W; Cho JG; Marchlinski FE
J Cardiovasc Electrophysiol; 1994 Apr; 5(4):313-22. PubMed ID: 8019707
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans.
Ranger S; Talajic M; Lemery R; Roy D; Villemaire C; Nattel S
Circulation; 1991 Jun; 83(6):1987-94. PubMed ID: 2040051
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of combination of IB and IC antiarrhythmics for the treatment of ventricular tachycardia.
Bleske BE; Kluger J; Fisher J; Chow MS
J Clin Pharmacol; 1989 Nov; 29(11):998-1002. PubMed ID: 2513339
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide.
Wynn J; Torres V; Flowers D; Mizruchi M; Keefe D; Miura D; Somberg J
Am Heart J; 1986 Apr; 111(4):632-8. PubMed ID: 3953384
[TBL] [Abstract][Full Text] [Related]
13. ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome.
Fujiki A; Usui M; Nagasawa H; Mizumaki K; Hayashi H; Inoue H
J Cardiovasc Electrophysiol; 1999 Feb; 10(2):214-8. PubMed ID: 10090224
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation.
Echt DS; Black JN; Barbey JT; Coxe DR; Cato E
Circulation; 1989 May; 79(5):1106-17. PubMed ID: 2469545
[TBL] [Abstract][Full Text] [Related]
15. Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
Long B; Koyfman A
J Emerg Med; 2017 Apr; 52(4):484-492. PubMed ID: 27751700
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
17. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
[TBL] [Abstract][Full Text] [Related]
18. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart.
Anderson KP; Walker R; Lux RL; Ershler PR; Menlove R; Williams MR; Krall R; Moddrelle D
Circulation; 1990 Mar; 81(3):1024-38. PubMed ID: 2155070
[TBL] [Abstract][Full Text] [Related]
19. Procainamide induced change of the width of the zone of entrainment and its relation to the inducibility of reentrant ventricular tachycardia.
Aizawa Y; Tanabe Y; Naitoh N; Washizuka T; Shibata A; Josephson ME
Pacing Clin Electrophysiol; 1997 Nov; 20(11):2789-98. PubMed ID: 9392810
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainide.
Kanemoto M; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kakugawa H; Kametani R; Inoue N; Sawa A; Matsuzaki M
Cardiovasc Drugs Ther; 2004 Jul; 18(4):295-303. PubMed ID: 15367827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
